Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.8301279736040317e-26,11.706514142788834,693.7611168273547,"['RPL30', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL9', 'RPL7', 'RPS15', 'RPS14', 'RPL18A', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPL21', 'RPL23', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL26', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPS3', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",8.894421951715594e-24,0,0,53
2,"GPCRs, Class A Rhodopsin-like WP455",8.908637847752202e-05,6.55,61.08467194810733,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'GPR34', 'HRH2', 'GPR65', 'FPR1', 'OPRM1']",0.02164798997003785,0,0,10
3,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.0001714523881229277,2.7079067569696016,23.48081447565092,"['UQCRB', 'NDUFB10', 'NDUFA4', 'COX4I1', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'ATP5MC3', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5F1E', 'ATP5MC1', 'UQCRQ', 'NDUFS6', 'UQCRFS1', 'SLC25A5', 'ATP5MF']",0.024248664290535477,0,0,23
4,NRF2 pathway WP2884,0.00019957748387271999,3.6484517304189437,31.08228403901261,"['HSP90AA1', 'PDGFB', 'SLC2A3', 'NRG1', 'SLC2A5', 'SLC6A1', 'SLC5A3', 'SLC6A6', 'DNAJB1', 'FTH1', 'HMOX1', 'FGF13', 'FTL', 'PPARD', 'HSPA1A']",0.024248664290535477,0,0,15
5,Complement system WP2806,0.0002555513836141947,4.37037037037037,36.152084181612,"['FCGR3A', 'SELPLG', 'CD93', 'PROS1', 'FPR1', 'ITGAX', 'SPP1', 'F13A1', 'VSIG4', 'CALR', 'CD55', 'TLR2']",0.024839594487299724,0,0,12
6,Complement Activation WP545,0.0014114562218834296,26.069114470842333,171.09507396462317,"['C1QB', 'C1QA', 'CD55', 'C1QC']",0.1143279539725578,0,0,4
7,Nonalcoholic fatty liver disease WP4396,0.001673627713951814,2.088333693071444,13.350219701566969,"['CEBPA', 'NDUFA13', 'UQCRB', 'NDUFB10', 'COX4I1', 'NDUFB3', 'NDUFB2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'MLX', 'UQCRFS1', 'XBP1', 'NDUFA4', 'INSR', 'NDUFA3', 'NDUFA1', 'COX6C', 'VMP1', 'UQCRQ', 'NDUFS6', 'CYCS', 'BAX']",0.11619758128294022,0,0,26
8,Nuclear Receptors Meta-Pathway WP2882,0.002211022290942153,2.0379266750948166,12.460495671373563,"['PDGFB', 'SLC2A3', 'SLC6A1', 'SLC2A5', 'SLC5A3', 'DNAJB1', 'SEC14L1', 'FTH1', 'ENC1', 'PDE4B', 'HMOX1', 'PLTP', 'HSP90AA1', 'STAT3', 'NRG1', 'SLC6A6', 'SLC7A5', 'SCD', 'BHLHE40', 'BAX', 'FGF13', 'CPEB4', 'PPARD', 'HSPA1A', 'FKBP5', 'FTL']",0.13431960417473582,0,0,26
9,Photodynamic therapy-induced unfolded protein response WP3613,0.0028214573638093883,5.078728782954135,29.814686115918143,"['DNAJC3', 'XBP1', 'HSPA5', 'EDEM1', 'DNAJB11', 'CALR', 'HSP90B1']",0.15235869764570698,0,0,7
10,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0035751702789886446,3.67671009771987,20.713637840212407,"['HDAC4', 'SCIN', 'HMGCS1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2', 'CALM2']",0.1533333460491252,0,0,9
11,Endochondral Ossification WP474,0.0035751702789886446,3.67671009771987,20.713637840212407,"['HDAC4', 'SCIN', 'HMGCS1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2', 'CALM2']",0.1533333460491252,0,0,9
12,Genes targeted by miRNAs in adipocytes WP1992,0.0037860085444228445,13.032397408207343,72.67442090077985,"['HDAC4', 'GJA1', 'TMSB4X', 'IGF1']",0.1533333460491252,0,0,4
13,Mitochondrial complex III assembly WP4921,0.00414269124475818,5.592764378478664,30.68419641835098,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.15487291884249813,0,0,6
14,Spinal Cord Injury WP2431,0.005732541950751733,2.578863884207396,13.311054090039148,"['C1QB', 'TNFSF13', 'AQP4', 'MIF', 'AIF1', 'TNFSF13B', 'RHOB', 'GJA1', 'ZFP36', 'GAP43', 'FCGR2A', 'APEX1', 'TLR4']",0.18729263663171705,0,0,13
15,Differentiation Pathway WP2848,0.005914214227309399,6.52,33.450186056608395,"['WNT2B', 'NOTCH1', 'WNT5A', 'PDGFB', 'IGF1']",0.18729263663171705,0,0,5
16,Lung fibrosis WP3624,0.006166012728616199,4.153944646902393,21.138190109641734,"['CEBPB', 'FAM13A', 'PDGFB', 'SPP1', 'HMOX1', 'ATP11A', 'IGF1']",0.18729263663171705,0,0,7
17,Development and heterogeneity of the ILC family WP3893,0.007903277721845462,8.68682505399568,42.04838299291472,"['IL15', 'ZBTB16', 'IL18', 'RORA']",0.21338849848982747,0,0,4
18,Differentiation of white and brown adipocyte WP2895,0.007903277721845462,8.68682505399568,42.04838299291472,"['PLAC8', 'CEBPA', 'CEBPB', 'PPARGC1B']",0.21338849848982747,0,0,4
19,Complement and Coagulation Cascades WP558,0.009540119509309976,4.348484848484849,20.230235446398066,"['C1QB', 'C1QA', 'PROS1', 'PLAT', 'CD55', 'C1QC']",0.24402621481708675,0,0,6
20,PI3K-Akt signaling pathway WP4172,0.01171989316089579,1.7223171951101506,7.658227623648952,"['CDKN1A', 'PHLPP1', 'PDGFB', 'HSP90B1', 'GNG10', 'CCND3', 'GNG3', 'SPP1', 'FGF20', 'ITGAV', 'JAK3', 'IFNAR2', 'HSP90AA1', 'IL4R', 'ANGPT2', 'INSR', 'RPS6', 'IGF1', 'FGF14', 'DDIT4', 'GRB2', 'SGK1', 'FGF13', 'PIK3AP1', 'TLR4', 'TLR2', 'CREB5']",0.2847934038097677,0,0,27
21,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.016858857926735717,2.671305892804264,10.906618912167321,"['RYR2', 'GJA1', 'CACNB4', 'CACNA2D3', 'ITGAV', 'CACNA1D', 'CTNNA3', 'CACNA1C', 'ACTG1']",0.34636444766164365,0,0,9
22,Selenium Micronutrient Network WP15,0.016858857926735717,2.671305892804264,10.906618912167321,"['PRDX3', 'SELENOM', 'PRDX5', 'KYNU', 'INSR', 'SELENOW', 'PLAT', 'SOD2', 'SELENOH']",0.34636444766164365,0,0,9
23,Monoamine GPCRs WP58,0.017806998062655136,inf,inf,"['CHRM3', 'HRH2']",0.34636444766164365,0,0,2
24,Osteoblast Signaling WP322,0.017806998062655136,inf,inf,"['PDGFB', 'ITGAV']",0.34636444766164365,0,0,2
25,HIF1A and PPARG regulation of glycolysis WP2456,0.019242469314535757,9.763754045307444,38.57303333712711,"['LDHA', 'TPI1', 'HIF1A']",0.34636444766164365,0,0,3
26,Insulin signaling in adipocytes (diabetic condition) WP3635,0.019242469314535757,9.763754045307444,38.57303333712711,"['TBC1D4', 'INSR', 'RPS6']",0.34636444766164365,0,0,3
27,Insulin signaling in adipocytes (normal condition) WP3634,0.019242469314535757,9.763754045307444,38.57303333712711,"['TBC1D4', 'INSR', 'RPS6']",0.34636444766164365,0,0,3
28,Mitochondrial CIV Assembly WP4922,0.02047424656247684,3.0442036836403035,11.837652232888697,"['PET100', 'NDUFA4', 'COX4I1', 'COX14', 'COX5B', 'COX6C', 'COX7C']",0.35537442247727663,0,0,7
29,TYROBP causal network in microglia WP3945,0.02466517847232319,2.119413531178237,7.846837833600792,"['IGSF6', 'ADAP2', 'DPYD', 'ITGAX', 'IL18', 'SPP1', 'TCIRG1', 'SLC1A5', 'TNFRSF1B', 'GAL3ST4', 'TGFBR1', 'C1QC']",0.4015165945778089,0,0,12
30,Ferroptosis WP4313,0.02607181964958285,2.6099783080260304,9.518330556743825,"['STEAP3', 'MAP1LC3A', 'ACSL1', 'FTH1', 'PCBP1', 'SLC40A1', 'HMOX1', 'FTL']",0.4015165945778089,0,0,8
31,ESC Pluripotency Pathways WP3931,0.031162128810289392,2.1129744607309737,7.328961245779943,"['FGF14', 'WNT2B', 'WNT5A', 'STAT3', 'PDGFB', 'FGF20', 'GAB1', 'GRB2', 'SMAD6', 'FGF13', 'MAP2K6']",0.4015165945778089,0,0,11
32,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.03319594262003577,1.57564810879728,5.365598025498021,"['CDKN1A', 'PHLPP1', 'PDGFB', 'SLC2A3', 'HIF1A', 'HSP90B1', 'GNG10', 'GNG3', 'SPP1', 'FGF20', 'ITGAX', 'ITGAV', 'JAK3', 'IFNAR2', 'HSP90AA1', 'IL4R', 'ANGPT2', 'INSR', 'RPS6', 'IGF1', 'FGF14', 'DDIT4', 'GRB2', 'FGF13', 'CREB5']",0.4015165945778089,0,0,25
33,"GPCRs, Other WP117",0.034080586941492554,4.341252699784017,14.66921162626881,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADGRL2']",0.4015165945778089,0,0,4
34,IL1 and megakaryocytes in obesity WP2865,0.034080586941492554,4.341252699784017,14.66921162626881,"['IL18', 'NLRP3', 'PLA2G7', 'TLR2']",0.4015165945778089,0,0,4
35,Iron metabolism in placenta WP2007,0.034080586941492554,4.341252699784017,14.66921162626881,"['STEAP3', 'FTH1', 'SLC40A1', 'HAMP']",0.4015165945778089,0,0,4
36,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.03469896496351435,6.508090614886731,21.87398815811243,"['CDKN1A', 'SPP1', 'ENPP1']",0.4015165945778089,0,0,3
37,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.03469896496351435,6.508090614886731,21.87398815811243,"['GRM5', 'GPRC5B', 'GRM7']",0.4015165945778089,0,0,3
38,Kynurenine Pathway and links to Cellular Senescence WP5044,0.03469896496351435,6.508090614886731,21.87398815811243,"['CDKN1A', 'KYNU', 'TLR4']",0.4015165945778089,0,0,3
39,Macrophage markers WP4146,0.03469896496351435,6.508090614886731,21.87398815811243,"['CD163', 'CD83', 'CD14']",0.4015165945778089,0,0,3
40,Platelet-mediated interactions with vascular and circulating cells WP4462,0.03469896496351435,6.508090614886731,21.87398815811243,"['SELPLG', 'TLR4', 'TLR2']",0.4015165945778089,0,0,3
41,Pyrimidine metabolism and related diseases WP4225,0.03469896496351435,6.508090614886731,21.87398815811243,"['NT5C', 'DPYD', 'TYMP']",0.4015165945778089,0,0,3
42,Transcriptional cascade regulating adipogenesis WP4211,0.03469896496351435,6.508090614886731,21.87398815811243,"['CEBPA', 'CEBPB', 'CEBPD']",0.4015165945778089,0,0,3
43,Calcium Regulation in the Cardiac Cell WP536,0.03656959111405682,1.737472617743702,5.748494575552292,"['CHRM3', 'RYR2', 'CACNA1B', 'CACNA1A', 'CACNA1D', 'CACNA1C', 'RGS4', 'GJA1', 'GNG3', 'RGS10', 'CALM3', 'CALR', 'PKIG', 'CALM2', 'RGS6', 'YWHAG', 'YWHAH']",0.41332142514957243,0,0,17
44,Glycolysis and Gluconeogenesis WP534,0.04045258872585486,2.5355724088118454,8.133164533382303,"['LDHA', 'TPI1', 'GOT1', 'PGAM1', 'SLC2A3', 'ALDOC', 'SLC2A5']",0.4468172300173968,0,0,7
45,Adipogenesis WP236,0.04336949689212338,1.9113661724852542,5.997864987980705,"['CEBPA', 'CDKN1A', 'CEBPB', 'CEBPD', 'SCD', 'NAMPT', 'STAT3', 'RORA', 'MIF', 'IGF1', 'HIF1A', 'PPARD']",0.46839056643493254,0,0,12
46,Vitamin D Receptor Pathway WP2877,0.04792612501319949,1.9406817045554805,5.895974443663375,"['CEBPA', 'CDKN1A', 'DUSP10', 'BCL6', 'SATB1', 'CREG2', 'S100A6', 'SPP1', 'CD14', 'HIF1A', 'PPARD']",0.47832661365772106,0,0,11
47,Genes controlling nephrogenesis WP4823,0.04803306776215121,3.720456649182351,11.294806333560066,"['ROBO2', 'CXCL12', 'PDGFB', 'NCK2']",0.47832661365772106,0,0,4
48,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.04867531568986961,13.006465517241379,39.313124711070344,"['CDKN1A', 'HIF1A']",0.47832661365772106,0,0,2
49,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.04867531568986961,13.006465517241379,39.313124711070344,"['STAT3', 'BAX']",0.47832661365772106,0,0,2
50,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.049210556960670886,2.401722073330672,7.233139331874559,"['FADS2', 'HMGCS1', 'ACSL1', 'SCD', 'CYP51A1', 'DHCR24', 'ABCG1']",0.47832661365772106,0,0,7
51,Oxidative Damage WP3941,0.05141387598682535,2.6064935064935066,7.735674408462678,"['C1QB', 'C1QA', 'CDKN1A', 'CYCS', 'TNFRSF1B', 'C1QC']",0.4899439946979827,0,0,6
52,Biomarkers for pyrimidine metabolism disorders WP4584,0.054795761841383246,4.880258899676376,14.172966923732062,"['NT5C', 'DPYD', 'TYMP']",0.4931618565724492,0,0,3
53,Dual hijack model of Vif in HIV infection WP3300,0.054795761841383246,4.880258899676376,14.172966923732062,"['ELOB', 'ELOC', 'RUNX1']",0.4931618565724492,0,0,3
54,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.054795761841383246,4.880258899676376,14.172966923732062,"['IL10RB', 'STAT3', 'HMOX1']",0.4931618565724492,0,0,3
55,MAPK Signaling Pathway WP382,0.05938490605776302,1.4819442708984132,4.184588550952767,"['DUSP3', 'LRRK2', 'CACNA2D3', 'PDGFB', 'CACNA1B', 'CACNA1A', 'CACNA1D', 'CACNA1C', 'TGFBR1', 'RASGRP3', 'RPS6KA5', 'CACNB4', 'FGF14', 'DUSP10', 'STMN1', 'RASA2', 'FGF20', 'GRB2', 'MAP3K8', 'CD14', 'FGF13', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.5247466244376877,0,0,24
56,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.06301624705956033,2.4431818181818183,6.753840677737488,"['NDUFA13', 'HSP90AA1', 'CASP1', 'IL18', 'NLRP3', 'NLRP1']",0.531101962762579,0,0,6
57,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.06466346230354053,3.2548596112311015,8.91362495780864,"['STAT3', 'SPP1', 'IGF1', 'TLR4']",0.531101962762579,0,0,4
58,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.06466346230354053,3.2548596112311015,8.91362495780864,"['LDHA', 'RPS6', 'HIF1A', 'PDK1']",0.531101962762579,0,0,4
59,Statin inhibition of cholesterol production WP430,0.06466346230354053,3.2548596112311015,8.91362495780864,"['LIPC', 'APOC2', 'APOC1', 'PLTP']",0.531101962762579,0,0,4
60,Neovascularisation processes WP4331,0.06556814355093568,2.7135135135135133,7.3934161590647225,"['NOTCH1', 'CXCL12', 'PDGFB', 'HIF1A', 'TGFBR1']",0.531101962762579,0,0,5
61,Cori Cycle WP1946,0.07918339642012737,3.9035598705501617,9.89938350015505,"['LDHA', 'TPI1', 'PGAM1']",0.5832449233205729,0,0,3
62,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.07918339642012737,3.9035598705501617,9.89938350015505,"['RAB27A', 'MYRIP', 'UNC13D']",0.5832449233205729,0,0,3
63,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.07918339642012737,3.9035598705501617,9.89938350015505,"['CYSLTR1', 'LTC4S', 'PPARD']",0.5832449233205729,0,0,3
64,Overview of nanoparticle effects WP3287,0.07918339642012737,3.9035598705501617,9.89938350015505,"['CCND3', 'HMOX1', 'BAX']",0.5832449233205729,0,0,3
65,Glucocorticoid Receptor Pathway WP2880,0.08222615146348293,2.073180340785975,5.179388885976594,"['HSP90AA1', 'MGAM', 'SEC14L1', 'ENC1', 'BHLHE40', 'PDE4B', 'CPEB4']",0.5832449233205729,0,0,7
66,Transcription factor regulation in adipogenesis WP3599,0.08388464268862379,2.892728581713463,7.169086054920369,"['CEBPA', 'CEBPB', 'CEBPD', 'INSR']",0.5832449233205729,0,0,4
67,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.08404656527300196,1.6031946678924385,3.9701260817575195,"['RYR2', 'SNAP25', 'CEBPB', 'AQP4', 'RORA', 'YBX1', 'HIF1A', 'HSP90B1', 'GJA1', 'BHLHE40', 'TPPP', 'PPARGC1B', 'YWHAG', 'YWHAH']",0.5832449233205729,0,0,14
68,Myometrial relaxation and contraction pathways WP289,0.08760500543697225,1.5363624662118678,3.74091530681144,"['RYR2', 'GUCY1A1', 'PDE4D', 'ACTG1', 'RGS4', 'GJA1', 'GNG3', 'PDE4B', 'RGS10', 'CALM3', 'PKIG', 'CALM2', 'RAMP1', 'RGS6', 'YWHAG', 'YWHAH']",0.5832449233205729,0,0,16
69,Caloric restriction and aging WP4191,0.08880684017638352,6.502155172413793,15.743613719960633,"['NAMPT', 'IGF1']",0.5832449233205729,0,0,2
70,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.08880684017638352,6.502155172413793,15.743613719960633,"['CYP51A1', 'DHCR24']",0.5832449233205729,0,0,2
71,Cysteine and methionine catabolism WP4504,0.08880684017638352,6.502155172413793,15.743613719960633,"['GOT1', 'SQOR']",0.5832449233205729,0,0,2
72,"GPCRs, Class B Secretin-like WP334",0.08880684017638352,6.502155172413793,15.743613719960633,"['ADGRE2', 'ADGRL2']",0.5832449233205729,0,0,2
73,Inflammatory Response Pathway WP453,0.08880684017638352,6.502155172413793,15.743613719960633,"['IL4R', 'TNFRSF1B']",0.5832449233205729,0,0,2
74,PTF1A related regulatory pathway WP4147,0.08880684017638352,6.502155172413793,15.743613719960633,"['NOTCH1', 'RBPJ']",0.5832449233205729,0,0,2
75,PPAR signaling pathway WP3942,0.09045230834715015,2.170995670995671,5.2167561567285885,"['FADS2', 'ACSL1', 'SCD', 'OLR1', 'PLTP', 'PPARD']",0.586130958089533,0,0,6
76,Nanoparticle triggered autophagic cell death WP2509,0.09864300850925938,2.325096525096525,5.3854999916817325,"['VMP1', 'ATG3', 'MAP1LC3A', 'INSR', 'ATG14']",0.622603923837663,0,0,5
77,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.09864300850925938,2.325096525096525,5.3854999916817325,"['LDHA', 'ANGPT2', 'BAX', 'SLC2A3', 'HIF1A']",0.622603923837663,0,0,5
78,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.10554434734741182,2.603023758099352,5.853221852218866,"['FCGR2A', 'NLRP3', 'TMEM173', 'IKBKE']",0.6286855223699171,0,0,4
79,White fat cell differentiation WP4149,0.10554434734741182,2.603023758099352,5.853221852218866,"['CEBPA', 'CEBPB', 'CEBPD', 'RORA']",0.6286855223699171,0,0,4
80,LTF danger signal response pathway WP4478,0.10736810361461548,3.2524271844660193,7.2577656585257415,"['CD14', 'TLR4', 'TLR2']",0.6286855223699171,0,0,3
81,Omega-9 FA synthesis WP4724,0.10736810361461548,3.2524271844660193,7.2577656585257415,"['FADS2', 'ACSL1', 'SCD']",0.6286855223699171,0,0,3
82,Peptide GPCRs WP24,0.10736810361461548,3.2524271844660193,7.2577656585257415,"['CX3CR1', 'FPR1', 'OPRM1']",0.6286855223699171,0,0,3
83,Triacylglyceride synthesis WP325,0.10736810361461548,3.2524271844660193,7.2577656585257415,"['LIPC', 'GK', 'PLPP3']",0.6286855223699171,0,0,3
84,Phosphodiesterases in neuronal function WP4222,0.12335105180664796,1.9532467532467532,4.08760032102111,"['GUCY1A1', 'PDE4D', 'PDE4B', 'PDE5A', 'PDE8B', 'GRIN2B']",0.6744564923425438,0,0,6
85,MECP2 and Associated Rett Syndrome WP3584,0.12390632853718465,1.675476966030712,3.498780282726174,"['RBFOX1', 'CEBPD', 'BCL6', 'RPS6', 'YBX1', 'NREP', 'IGF1', 'SGK1', 'FKBP5']",0.6744564923425438,0,0,9
86,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.12390632853718465,1.675476966030712,3.498780282726174,"['NHSL1', 'NOTCH1', 'TG', 'TBC1D4', 'RPS6', 'ITGAV', 'GRB2', 'TTF2', 'MGLL']",0.6744564923425438,0,0,9
87,Nuclear receptors WP170,0.12943936586835467,2.3659925387787157,4.837372831909499,"['ESRRA', 'RORA', 'NR1D2', 'PPARD']",0.6744564923425438,0,0,4
88,"COVID-19, thrombosis and anticoagulation WP4927",0.13350534050835192,inf,inf,['F13A1'],0.6744564923425438,0,0,1
89,Gastric acid production WP2596,0.13350534050835192,inf,inf,['CCK'],0.6744564923425438,0,0,1
90,SCFA and skeletal muscle substrate metabolism WP4030,0.13350534050835192,inf,inf,['PPARD'],0.6744564923425438,0,0,1
91,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.13350534050835192,inf,inf,['HRH2'],0.6744564923425438,0,0,1
92,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.1351831231046841,4.334051724137931,8.672979049611806,"['CASP1', 'NLRP3']",0.6744564923425438,0,0,2
93,Nanomaterial-induced inflammasome activation WP3890,0.1351831231046841,4.334051724137931,8.672979049611806,"['CASP1', 'TLR4']",0.6744564923425438,0,0,2
94,NOTCH1 regulation of endothelial cell calcification WP3413,0.1351831231046841,4.334051724137931,8.672979049611806,"['NOTCH1', 'PLAT']",0.6744564923425438,0,0,2
95,TCA cycle in senescence WP5050,0.1351831231046841,4.334051724137931,8.672979049611806,"['GOT1', 'PDK1']",0.6744564923425438,0,0,2
96,Tryptophan catabolism leading to NAD+ production WP4210,0.1351831231046841,4.334051724137931,8.672979049611806,"['KYNU', 'NAMPT']",0.6744564923425438,0,0,2
97,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.1385258441416897,2.0337837837837838,4.020177091276238,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR4', 'TLR2']",0.6744564923425438,0,0,5
98,Cardiac Progenitor Differentiation WP2406,0.13877705603756044,2.787332408691632,5.504665275653496,"['NOTCH1', 'NRG1', 'IGF1']",0.6744564923425438,0,0,3
99,Nucleotide metabolism WP404,0.13877705603756044,2.787332408691632,5.504665275653496,"['POLB', 'OAZ1', 'SRM']",0.6744564923425438,0,0,3
100,Vitamin B12 metabolism WP1533,0.13877705603756044,2.787332408691632,5.504665275653496,"['INSR', 'PLAT', 'SOD2']",0.6744564923425438,0,0,3
101,Synaptic Vesicle Pathway WP2267,0.14023210070857106,1.6807781120985235,3.301815263667017,"['SNAP25', 'SLC38A1', 'RAB3A', 'CACNA1B', 'CACNA1A', 'SYN3', 'CPLX1', 'STX1A']",0.6747802073699558,0,0,8
102,Allograft Rejection WP2328,0.1418343297395414,1.7530627552296025,3.423899144069846,"['C1QB', 'C1QA', 'CXCL12', 'GNLY', 'LRRK2', 'CD55', 'C1QC']",0.6757988652295797,0,0,7
103,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.1607345554095348,1.913831478537361,3.4984858543078623,"['IRAK2', 'LY96', 'PLAT', 'CD14', 'TLR4']",0.7511249416253261,0,0,5
104,Type 2 papillary renal cell carcinoma WP4241,0.1607345554095348,1.913831478537361,3.4984858543078623,"['CDKN1A', 'PDGFB', 'ELOB', 'ELOC', 'HIF1A']",0.7511249416253261,0,0,5
105,Oxidative phosphorylation WP623,0.16725543661721975,1.5424309960569176,2.7582261223902367,"['NDUFB10', 'NDUFS6', 'NDUFA4', 'NDUFA3', 'NDUFB2', 'ATP5MC3', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",0.77022784672261,0,0,9
106,Gastric Cancer Network 2 WP2363,0.1728060632640146,2.4385113268608416,4.281014724410644,"['PLAC8', 'RNF144B', 'S100A6']",0.77022784672261,0,0,3
107,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.1728060632640146,2.4385113268608416,4.281014724410644,"['IL4R', 'STAT3', 'TLR4']",0.77022784672261,0,0,3
108,Type II diabetes mellitus WP1584,0.1728060632640146,2.4385113268608416,4.281014724410644,"['GK', 'INSR', 'CACNA1A']",0.77022784672261,0,0,3
109,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.17770639978310257,1.6273022751895991,2.8113640736299663,"['ANGPT2', 'MSH2', 'STMN1', 'PXN', 'STAT3', 'BAX', 'GRB2']",0.77022784672261,0,0,7
110,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.1818634610530775,1.6976284584980237,2.8936061583403294,"['CEBPA', 'CDKN1A', 'CEBPB', 'NOTCH1', 'CEBPD', 'SPP1']",0.77022784672261,0,0,6
111,Neural Crest Differentiation WP2064,0.18426272992555587,1.8072072072072072,3.056697004997587,"['HDAC4', 'NOTCH1', 'TCF4', 'RBPJ', 'RHOB']",0.77022784672261,0,0,5
112,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.18542522235914685,3.25,5.47658667456481,"['TLR4', 'TLR2']",0.77022784672261,0,0,2
113,Glial Cell Differentiation WP2276,0.18542522235914685,3.25,5.47658667456481,"['GAP43', 'TPPP']",0.77022784672261,0,0,2
114,LDLRAD4 and what we know about it WP4904,0.18542522235914685,3.25,5.47658667456481,"['PMEPA1', 'TGFBR1']",0.77022784672261,0,0,2
115,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.18542522235914685,3.25,5.47658667456481,"['ABCG1', 'PPARD']",0.77022784672261,0,0,2
116,Osteoclast Signaling WP12,0.18542522235914685,3.25,5.47658667456481,"['PDGFB', 'SPP1']",0.77022784672261,0,0,2
117,Urea cycle and metabolism of amino groups WP497,0.18542522235914685,3.25,5.47658667456481,"['OAT', 'SRM']",0.77022784672261,0,0,2
118,Pathogenic Escherichia coli infection WP2272,0.19006731668984728,1.5317085619497257,2.5432136228556037,"['TUBB3', 'ARPC5L', 'NCK2', 'LY96', 'CD14', 'TLR5', 'TLR4', 'ACTG1']",0.782819626366659,0,0,8
119,Regulatory circuits of the STAT3 signaling pathway WP4538,0.19695150118234492,1.5709268875854596,2.55243849976781,"['PTPRT', 'IFNAR2', 'IL10RB', 'STMN1', 'STAT3', 'JAK3', 'CSF2RA']",0.8043565510472237,0,0,7
120,Acute viral myocarditis WP4298,0.20814823047658032,1.487697551905795,2.334948458439687,"['STAT3', 'CASP1', 'CYCS', 'BAX', 'TLR5', 'TLR4', 'AIF1', 'CD55']",0.8189479623893636,0,0,8
121,Monoamine Transport WP727,0.20885360374634748,2.1672060409924487,3.3941084806833137,"['SLC6A1', 'NECTIN2', 'STX1A']",0.8189479623893636,0,0,3
122,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.20885360374634748,2.1672060409924487,3.3941084806833137,"['P4HA1', 'P3H2', 'PPIB']",0.8189479623893636,0,0,3
123,Disruption of postsynaptic signaling by CNV WP4875,0.20894968587712157,1.7118065433854908,2.680110102720892,"['RYR2', 'DLGAP1', 'GRIN2B', 'YWHAG', 'STX1A']",0.8189479623893636,0,0,5
124,Hepatitis C and Hepatocellular Carcinoma WP3646,0.20894968587712157,1.7118065433854908,2.680110102720892,"['CDKN1A', 'STAT3', 'GRB2', 'HIF1A', 'TGFBR1']",0.8189479623893636,0,0,5
125,Fatty acid beta-oxidation WP143,0.21201586630063696,1.8580684973773527,2.8820392064401568,"['LIPC', 'TPI1', 'GK', 'ACSL1']",0.8218402006687348,0,0,4
126,DNA damage response (only ATM dependent) WP710,0.21306968165485715,1.3774169247509835,2.129673925845032,"['CCND3', 'CDKN1A', 'WNT2B', 'MLKL', 'BCL6', 'INSR', 'WNT5A', 'BAX', 'GRB2', 'SOD2', 'PDK1']",0.8218402006687348,0,0,11
127,Mitochondrial complex I assembly model OXPHOS system WP4324,0.21696974120198587,1.5183098591549296,2.319973481700266,"['NDUFA13', 'NDUFB10', 'NDUFS6', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1']",0.8295410411344895,0,0,7
128,Toll-like Receptor Signaling Pathway WP75,0.22331687010452547,1.3850601295097131,2.076431693866881,"['IFNAR2', 'SPP1', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.8295410411344895,0,0,10
129,Apoptosis Modulation and Signaling WP1772,0.22686865381307736,1.4461315979754157,2.1451685416167954,"['CAPNS1', 'CASP4', 'CASP1', 'CYCS', 'BAX', 'TNFRSF1B', 'TNFRSF10D', 'HSPA1A']",0.8295410411344895,0,0,8
130,NO/cGMP/PKG mediated Neuroprotection WP4008,0.23462668319957453,1.625945945945946,2.357230760641433,"['GUCY1A1', 'TSPO', 'CYCS', 'GRIN2B', 'CALM2']",0.8295410411344895,0,0,5
131,7-oxo-C and 7beta-HC pathways WP5064,0.23767701471365416,2.5995689655172414,3.7351714521264228,"['DBP', 'ACOT7']",0.8295410411344895,0,0,2
132,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.23767701471365416,2.5995689655172414,3.7351714521264228,"['STAT3', 'TCF4']",0.8295410411344895,0,0,2
133,Nanomaterial induced apoptosis WP2507,0.23767701471365416,2.5995689655172414,3.7351714521264228,"['BAX', 'CYCS']",0.8295410411344895,0,0,2
134,The influence of laminopathies on Wnt signaling WP4844,0.2422486297680092,1.7339092872570194,2.4583204352404575,"['CEBPA', 'CEBPB', 'CEBPD', 'SPP1']",0.8295410411344895,0,0,4
135,Folate Metabolism WP176,0.24634429446050962,1.9501618122977347,2.732225746688233,"['INSR', 'PLAT', 'SOD2']",0.8295410411344895,0,0,3
136,IL-9 signaling pathway WP22,0.24634429446050962,1.9501618122977347,2.732225746688233,"['STAT3', 'GRB2', 'JAK3']",0.8295410411344895,0,0,3
137,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.24634429446050962,1.9501618122977347,2.732225746688233,"['TLR5', 'TLR4', 'TLR2']",0.8295410411344895,0,0,3
138,Biomarkers for urea cycle disorders WP4583,0.24920368725439396,6.496232508073197,9.026415650406433,['GOT1'],0.8295410411344895,0,0,1
139,Blood Clotting Cascade WP272,0.24920368725439396,6.496232508073197,9.026415650406433,['PLAT'],0.8295410411344895,0,0,1
140,Dopaminergic Neurogenesis WP2855,0.24920368725439396,6.496232508073197,9.026415650406433,['STAT3'],0.8295410411344895,0,0,1
141,Gene regulatory network modelling somitogenesis  WP2854,0.24920368725439396,6.496232508073197,9.026415650406433,['NOTCH1'],0.8295410411344895,0,0,1
142,Hfe effect on hepcidin production WP3924,0.24920368725439396,6.496232508073197,9.026415650406433,['HAMP'],0.8295410411344895,0,0,1
143,NAD Biosynthesis II (from tryptophan) WP2485,0.24920368725439396,6.496232508073197,9.026415650406433,['KYNU'],0.8295410411344895,0,0,1
144,Nephrogenesis WP5052,0.24920368725439396,6.496232508073197,9.026415650406433,['FGF20'],0.8295410411344895,0,0,1
145,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.24920368725439396,6.496232508073197,9.026415650406433,['NOTCH1'],0.8295410411344895,0,0,1
146,Thyroxine (Thyroid Hormone) Production WP1981,0.24920368725439396,6.496232508073197,9.026415650406433,['TG'],0.8295410411344895,0,0,1
147,3q29 copy number variation syndrome WP4906,0.25899644855122816,1.4229414951245938,1.922309906096164,"['DYNLT3', 'PXN', 'SLC40A1', 'DYNLL1', 'HIF1A', 'HAMP', 'PIGX']",0.8562739727612033,0,0,7
148,Non-small cell lung cancer WP4255,0.2659727982136396,1.3695627354720858,1.813795799573101,"['CDKN1A', 'STAT3', 'CYCS', 'BAX', 'E2F3', 'GRB2', 'JAK3', 'PDK1']",0.8661778817718243,0,0,8
149,Toll-like Receptor Signaling related to MyD88 WP3858,0.27336456284956295,1.625269978401728,2.1078922400476943,"['TLR5', 'IKBKE', 'TLR4', 'TLR2']",0.8661778817718243,0,0,4
150,IL-18 signaling pathway WP4754,0.2817536263977509,1.1896056742379464,1.5068999824315172,"['CEBPB', 'NRN1', 'CD83', 'SEMA6D', 'IL18', 'TNFAIP2', 'PLA2G7', 'GRIN2B', 'GRM7', 'TMSB4X', 'STMN1', 'NFKBIZ', 'SPP1', 'HMOX1', 'CYCS', 'BAX', 'KIFC3', 'RPS11', 'CDK5R2']",0.8661778817718243,0,0,19
151,NRF2-ARE regulation WP4357,0.2847442784347529,1.772580170638423,2.2266509900421996,"['CEBPB', 'INSR', 'HMOX1']",0.8661778817718243,0,0,3
152,Prostaglandin Synthesis and Regulation WP98,0.2847442784347529,1.772580170638423,2.2266509900421996,"['HPGDS', 'S100A6', 'PPARGC1B']",0.8661778817718243,0,0,3
153,Alzheimer's disease WP2059,0.2862225117767677,1.334223260470549,1.6690942961100805,"['ATP5MD', 'VMP1', 'CYCS', 'CACNA1D', 'CALM3', 'CACNA1C', 'GRIN2B', 'CALM2']",0.8661778817718243,0,0,8
154,CAMKK2  Pathway WP4874,0.28825886751845475,1.4776412776412777,1.8380326022340978,"['HDAC4', 'CHRM3', 'MAP1LC3A', 'HMOX1', 'CALM2']",0.8661778817718243,0,0,5
155,Base Excision Repair WP4752,0.2905082196065995,2.165948275862069,2.6773793651840205,"['POLB', 'APEX1']",0.8661778817718243,0,0,2
156,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.2905082196065995,2.165948275862069,2.6773793651840205,"['RYR2', 'CCK']",0.8661778817718243,0,0,2
157,Fluoropyrimidine Activity WP1601,0.2905082196065995,2.165948275862069,2.6773793651840205,"['DPYD', 'TYMP']",0.8661778817718243,0,0,2
158,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.2905082196065995,2.165948275862069,2.6773793651840205,"['ELOB', 'ELOC']",0.8661778817718243,0,0,2
159,"NAD metabolism, sirtuins and aging WP3630",0.2905082196065995,2.165948275862069,2.6773793651840205,"['NAMPT', 'HIF1A']",0.8661778817718243,0,0,2
160,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.2905082196065995,2.165948275862069,2.6773793651840205,"['STAT3', 'JAK3']",0.8661778817718243,0,0,2
161,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.2905082196065995,2.165948275862069,2.6773793651840205,"['PDGFB', 'IGF1']",0.8661778817718243,0,0,2
162,Omega-3/Omega-6 FA synthesis WP4723,0.2905082196065995,2.165948275862069,2.6773793651840205,"['FADS2', 'ACSL1']",0.8661778817718243,0,0,2
163,Proteoglycan biosynthesis WP4784,0.2905082196065995,2.165948275862069,2.6773793651840205,"['CSGALNACT1', 'CHSY1']",0.8661778817718243,0,0,2
164,7q11.23 copy number variation syndrome WP4932,0.29254717762679633,1.2755754475703325,1.567847200701704,"['GRIP1', 'SNAP25', 'VPS9D1', 'ATP5MC3', 'DDX21', 'GRB2', 'NRG1', 'STX1A', 'ATP5F1E', 'ATP5MC1']",0.8668305335827394,0,0,10
165,Ectoderm Differentiation WP2858,0.2942943169571029,1.2555409197640457,1.5357461820465828,"['SDCBP', 'PLCXD3', 'ZBTB16', 'ARHGDIG', 'PIM1', 'SORCS1', 'LDB2', 'KIFC3', 'CDH8', 'ASTN1', 'PPARD']",0.8668305335827394,0,0,11
166,Notch Signaling Pathway Netpath WP61,0.2973182990244576,1.3933209647495362,1.6900314510685661,"['CDKN1A', 'NOTCH1', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.8704620079872675,0,0,6
167,Cardiac Hypertrophic Response WP2795,0.3030975877833711,1.3387929386272386,1.5981177378942044,"['HDAC4', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'TGFBR1', 'MAP2K6']",0.8754710122667343,0,0,7
168,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3104668553385637,1.1045515139973339,1.2919697487160808,"['HDAC4', 'PXN', 'ARPC5L', 'HTRA1', 'IQGAP1', 'LDB2', 'RPL10A', 'SLC7A1', 'RPL7', 'ACTG1', 'SDCBP', 'GJA1', 'LDHA', 'RPS6KA5', 'RPL18A', 'TMSB4X', 'RPLP2', 'ITGAV', 'ELOC', 'RPS11', 'TMSB10', 'MAP2K6', 'TMOD1', 'PTPN1', 'HSP90AA1', 'SEMA6D', 'STAT3', 'RPS6', 'GAB1', 'SOD2', 'PTPN14', 'FMNL3', 'INPP4B', 'TXNIP', 'CYCS', 'GRB2', 'RPL26', 'CALR', 'PFN1', 'HSPA1A']",0.8754710122667343,0,0,40
169,IL-4 signaling pathway WP395,0.32206558496079946,1.345051500223914,1.5239434495231607,"['CEBPA', 'CEBPB', 'IL4R', 'STAT3', 'GRB2', 'JAK3']",0.8754710122667343,0,0,6
170,Immune response to tuberculosis WP4197,0.32357050135904086,1.6245954692556634,1.8330932179679542,"['IFNAR2', 'OAS1', 'PTPN2']",0.8754710122667343,0,0,3
171,Oncostatin M Signaling Pathway WP2374,0.325703638633984,1.3003250270855904,1.4586622183230957,"['CEBPB', 'RPS6', 'PXN', 'STAT3', 'GRB2', 'JAK3', 'HIF1A']",0.8754710122667343,0,0,7
172,Cholesterol Biosynthesis Pathway WP197,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['HMGCS1', 'CYP51A1']",0.8754710122667343,0,0,2
173,Computational Model of Aerobic Glycolysis WP4629,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['LDHA', 'TPI1']",0.8754710122667343,0,0,2
174,Glycolysis in senescence WP5049,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['LDHA', 'ALDOC']",0.8754710122667343,0,0,2
175,Leptin Insulin Overlap WP3935,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['INSR', 'STAT3']",0.8754710122667343,0,0,2
176,miRNAs involved in DNA damage response WP1545,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['CDKN1A', 'CCND3']",0.8754710122667343,0,0,2
177,Osteopontin Signaling WP1434,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['SPP1', 'ITGAV']",0.8754710122667343,0,0,2
178,Oxysterols derived from cholesterol WP4545,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['DBP', 'ACOT7']",0.8754710122667343,0,0,2
179,Phytochemical activity on NRF2 transcriptional activation WP3,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['CEBPB', 'HMOX1']",0.8754710122667343,0,0,2
180,TP53 network WP1742,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['CDKN1A', 'BAX']",0.8754710122667343,0,0,2
181,Urea cycle and associated pathways WP4595,0.3428339585295525,1.8562192118226601,1.9870994370914612,"['OAT', 'GOT1']",0.8754710122667343,0,0,2
182,Regulation of toll-like receptor signaling pathway WP1449,0.34524426345609194,1.1824123588829472,1.2574992120519333,"['IFNAR2', 'IRAK2', 'SPP1', 'LY96', 'MAP3K8', 'CD14', 'SMAD6', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.8754710122667343,0,0,12
183,Breast cancer pathway WP4262,0.3485900998675088,1.2190553745928339,1.2847119245510321,"['CDKN1A', 'NOTCH1', 'WNT2B', 'WNT5A', 'FGF20', 'BAX', 'GRB2', 'E2F3', 'IGF1']",0.8754710122667343,0,0,9
184,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.34893073235720584,1.2383018283235203,1.3037855212252758,"['RPS6', 'STAT3', 'GAB1', 'PDGFB', 'BAX', 'NRG1', 'GRB2', 'IGF1']",0.8754710122667343,0,0,8
185,Cellular Proteostasis WP4918,0.34946785263322316,3.247578040904198,3.4143207218754927,['PFDN5'],0.8754710122667343,0,0,1
186,EV release from cardiac cells and their functional effects WP3297,0.34946785263322316,3.247578040904198,3.4143207218754927,['CXCL12'],0.8754710122667343,0,0,1
187,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.34946785263322316,3.247578040904198,3.4143207218754927,['CEBPB'],0.8754710122667343,0,0,1
188,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.34946785263322316,3.247578040904198,3.4143207218754927,['FADS2'],0.8754710122667343,0,0,1
189,Liver X receptor pathway WP2874,0.34946785263322316,3.247578040904198,3.4143207218754927,['SCD'],0.8754710122667343,0,0,1
190,Metabolism of alpha-linolenic acid WP4586,0.34946785263322316,3.247578040904198,3.4143207218754927,['FADS2'],0.8754710122667343,0,0,1
191,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.34946785263322316,3.247578040904198,3.4143207218754927,['HIF1A'],0.8754710122667343,0,0,1
192,miR-517 relationship with ARCN1 and USP1 WP3596,0.34946785263322316,3.247578040904198,3.4143207218754927,['CDKN1A'],0.8754710122667343,0,0,1
193,Peroxiredoxin 2 induced ovarian failure WP4873,0.34946785263322316,3.247578040904198,3.4143207218754927,['BAX'],0.8754710122667343,0,0,1
194,Sulfation Biotransformation Reaction WP692,0.34946785263322316,3.247578040904198,3.4143207218754927,['SULT4A1'],0.8754710122667343,0,0,1
195,Bladder cancer WP2828,0.36239543643148614,1.499377645008713,1.5218972439553602,"['CDKN1A', 'RPS6KA5', 'TYMP']",0.8940313812472196,0,0,3
196,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.36239543643148614,1.499377645008713,1.5218972439553602,"['CEBPA', 'PTPN1', 'CEBPB']",0.8940313812472196,0,0,3
197,Unfolded protein response WP4925,0.36239543643148614,1.499377645008713,1.5218972439553602,"['XBP1', 'HSPA5', 'TXNIP']",0.8940313812472196,0,0,3
198,Integrated Cancer Pathway WP1971,0.36936171311536664,1.367966352165511,1.362465571682754,"['CDKN1A', 'MSH2', 'BAX', 'BACH1']",0.8986394863308372,0,0,4
199,Vitamin D-sensitive calcium signaling in depression WP4698,0.36936171311536664,1.367966352165511,1.362465571682754,"['GRM5', 'ATP2B4', 'CACNA1C', 'GRIN2B']",0.8986394863308372,0,0,4
200,Microglia Pathogen Phagocytosis Pathway WP3937,0.37185426311526754,1.2996756756756758,1.2857084085774744,"['C1QB', 'C1QA', 'FCER1G', 'FCGR1A', 'C1QC']",0.8986394863308372,0,0,5
201,Exercise-induced Circadian Regulation WP410,0.3722726471948123,1.2578550481776287,1.2429227623473442,"['CEBPB', 'TUBB3', 'SUMO3', 'NR1D2', 'ERC2', 'ARNTL']",0.8986394863308372,0,0,6
202,Prolactin Signaling Pathway WP2037,0.3916755428522931,1.1816209820548216,1.107558726194689,"['PTPN1', 'RPS6', 'PXN', 'STAT3', 'GRB2', 'PPIB', 'CTSD', 'YWHAG']",0.8986394863308372,0,0,8
203,Apoptosis Modulation by HSP70 WP384,0.39384816993512,1.6239224137931034,1.5131543402663024,"['CYCS', 'HSPA1A']",0.8986394863308372,0,0,2
204,Canonical and non-canonical Notch signaling WP3845,0.39384816993512,1.6239224137931034,1.5131543402663024,"['NOTCH1', 'RBPJ']",0.8986394863308372,0,0,2
205,Development of ureteric collection system WP5053,0.39384816993512,1.6239224137931034,1.5131543402663024,"['ROBO2', 'GRIP1']",0.8986394863308372,0,0,2
206,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.39384816993512,1.6239224137931034,1.5131543402663024,"['OAS1', 'TMEM173']",0.8986394863308372,0,0,2
207,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.39384816993512,1.6239224137931034,1.5131543402663024,"['LDHA', 'SLC2A3']",0.8986394863308372,0,0,2
208,Sleep regulation WP3591,0.39384816993512,1.6239224137931034,1.5131543402663024,"['PER3', 'IL18']",0.8986394863308372,0,0,2
209,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.39384816993512,1.6239224137931034,1.5131543402663024,"['HMGCS1', 'SCD']",0.8986394863308372,0,0,2
210,Striated Muscle Contraction Pathway WP383,0.39384816993512,1.6239224137931034,1.5131543402663024,"['TMOD1', 'ACTG1']",0.8986394863308372,0,0,2
211,Tryptophan metabolism WP465,0.39384816993512,1.6239224137931034,1.5131543402663024,"['KYNU', 'DHCR24']",0.8986394863308372,0,0,2
212,Wnt signaling in kidney disease WP4150,0.39384816993512,1.6239224137931034,1.5131543402663024,"['WNT2B', 'WNT5A']",0.8986394863308372,0,0,2
213,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.39384816993512,1.6239224137931034,1.5131543402663024,"['ZBTB16', 'PPARD']",0.8986394863308372,0,0,2
214,Retinoblastoma gene in cancer WP2446,0.39750880457675064,1.218344155844156,1.1239690187312588,"['CDKN1A', 'CCND3', 'H2AFZ', 'STMN1', 'E2F3', 'SAP30']",0.9007646401184088,0,0,6
215,p53 transcriptional gene network WP4963,0.39991988441736837,1.2494802494802495,1.1451374544192074,"['CDKN1A', 'NOTCH1', 'MSH2', 'BAX', 'TNFRSF10D']",0.9007646401184088,0,0,5
216,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.4014441092569593,1.2993520518358532,1.1859016743218143,"['CDKN1A', 'HSP90AA1', 'BAX', 'MAP2K6']",0.9007646401184088,0,0,4
217,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.41312766925080385,1.1551699204627621,1.0211686008557446,"['HDAC4', 'WNT5A', 'STAT3', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.9007646401184088,0,0,8
218,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.42269286138455997,1.1812278630460449,1.0171664869169754,"['EIF4A2', 'RPS6KA5', 'RPS6', 'PIM1', 'PDK1', 'MAP2K6']",0.9007646401184088,0,0,6
219,Metabolic reprogramming in colon cancer WP4290,0.43321884604263144,1.2372724467756866,1.0349935713661451,"['LDHA', 'PGAM1', 'SLC1A5', 'SLC16A3']",0.9007646401184088,0,0,4
220,p38 MAPK Signaling Pathway WP400,0.43321884604263144,1.2372724467756866,1.0349935713661451,"['RPS6KA5', 'GRB2', 'TGFBR1', 'MAP2K6']",0.9007646401184088,0,0,4
221,Alanine and aspartate metabolism WP106,0.43635482242259993,2.1646932185145316,1.7951791200188674,['GOT1'],0.9007646401184088,0,0,1
222,Farnesoid X receptor pathway WP2879,0.43635482242259993,2.1646932185145316,1.7951791200188674,['FKBP5'],0.9007646401184088,0,0,1
223,Glucuronidation WP698,0.43635482242259993,2.1646932185145316,1.7951791200188674,['PGM5'],0.9007646401184088,0,0,1
224,Glutathione metabolism WP100,0.43635482242259993,2.1646932185145316,1.7951791200188674,['IDH1'],0.9007646401184088,0,0,1
225,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.43635482242259993,2.1646932185145316,1.7951791200188674,['LIPC'],0.9007646401184088,0,0,1
226,Metastatic brain tumor WP2249,0.43635482242259993,2.1646932185145316,1.7951791200188674,['E2F3'],0.9007646401184088,0,0,1
227,Mevalonate pathway WP3963,0.43635482242259993,2.1646932185145316,1.7951791200188674,['HMGCS1'],0.9007646401184088,0,0,1
228,Role of Osx and miRNAs in tooth development WP3971,0.43635482242259993,2.1646932185145316,1.7951791200188674,['NOTCH1'],0.9007646401184088,0,0,1
229,Serotonin Transporter Activity WP1455,0.43635482242259993,2.1646932185145316,1.7951791200188674,['STX1A'],0.9007646401184088,0,0,1
230,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.43635482242259993,2.1646932185145316,1.7951791200188674,['STAT3'],0.9007646401184088,0,0,1
231,Thiamine metabolic pathways WP4297,0.43635482242259993,2.1646932185145316,1.7951791200188674,['SLC25A19'],0.9007646401184088,0,0,1
232,Trans-sulfuration pathway WP2333,0.43635482242259993,2.1646932185145316,1.7951791200188674,['GOT1'],0.9007646401184088,0,0,1
233,Aryl Hydrocarbon Receptor Pathway WP2873,0.43861499189434994,1.2990291262135922,1.0705731116569912,"['SLC7A5', 'HSP90AA1', 'BAX']",0.9007646401184088,0,0,3
234,EPO Receptor Signaling WP581,0.43861499189434994,1.2990291262135922,1.0705731116569912,"['STAT3', 'GRB2', 'PDK1']",0.9007646401184088,0,0,3
235,IL17 signaling pathway WP2112,0.43861499189434994,1.2990291262135922,1.0705731116569912,"['CEBPB', 'CEBPD', 'STAT3']",0.9007646401184088,0,0,3
236,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4408153407765465,1.1368364030335862,0.9312159156574664,"['HSPA5', 'TUBB3', 'PSMD5', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.9007646401184088,0,0,7
237,Angiogenesis WP1539,0.4429686193174891,1.4432471264367817,1.175173134724212,"['PDGFB', 'HIF1A']",0.9007646401184088,0,0,2
238,Mitochondrial Gene Expression WP391,0.4429686193174891,1.4432471264367817,1.175173134724212,"['ESRRA', 'PPARGC1B']",0.9007646401184088,0,0,2
239,Pre-implantation embryo WP3527,0.4429686193174891,1.4432471264367817,1.175173134724212,"['ESRRA', 'ZFP36']",0.9007646401184088,0,0,2
240,Regulation of Actin Cytoskeleton WP51,0.44807632595004265,1.0827886710239651,0.8692537478326972,"['CHRM3', 'FGF14', 'TMSB4X', 'PXN', 'PDGFB', 'FGF20', 'IQGAP1', 'CD14', 'PFN1', 'SSH2', 'FGF13', 'ACTG1']",0.9072718372906645,0,0,12
241,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.45550273312535416,1.15984555984556,0.9120486873833487,"['BEX3', 'CDKN1A', 'HSPA5', 'NRG1', 'YBX3']",0.9072718372906645,0,0,5
242,G13 Signaling Pathway WP524,0.45550273312535416,1.15984555984556,0.9120486873833487,"['ARHGDIG', 'IQGAP1', 'IQGAP2', 'PFN1', 'CALM2']",0.9072718372906645,0,0,5
243,Pyrimidine metabolism WP4022,0.45550273312535416,1.15984555984556,0.9120486873833487,"['NT5C', 'DPYD', 'ENPP1', 'POLR2I', 'TYMP']",0.9072718372906645,0,0,5
244,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.45550273312535416,1.15984555984556,0.9120486873833487,"['ADAMTSL2', 'STAT3', 'SPP1', 'SMAD6', 'TGFBR1']",0.9072718372906645,0,0,5
245,Pathways in clear cell renal cell carcinoma WP4018,0.46368826521040934,1.1089237111222683,0.8522553281236962,"['LDHA', 'TPI1', 'PGBD5', 'STAT3', 'PDGFB', 'ALDOC', 'HIF1A']",0.9198061097643222,0,0,7
246,Amino Acid metabolism WP3925,0.472520730875406,1.1133580705009276,0.8346552175346045,"['LDHA', 'OAT', 'GOT1', 'IDH1', 'IARS', 'SRM']",0.9200303563021659,0,0,6
247,Apoptosis WP254,0.472520730875406,1.1133580705009276,0.8346552175346045,"['CASP4', 'CASP1', 'CYCS', 'BAX', 'IGF1', 'TNFRSF1B']",0.9200303563021659,0,0,6
248,Melanoma WP4685,0.472520730875406,1.1133580705009276,0.8346552175346045,"['CDKN1A', 'BAX', 'E2F3', 'CALM3', 'GRB2', 'CALM2']",0.9200303563021659,0,0,6
249,MET in type 1 papillary renal cell carcinoma WP4205,0.472520730875406,1.1133580705009276,0.8346552175346045,"['CDKN1A', 'RPL11', 'STAT3', 'GAB1', 'GRB2', 'JAK3']",0.9200303563021659,0,0,6
250,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4754336687281101,1.2176375404530744,0.9053474891011196,"['FIG4', 'RAB3A', 'LITAF']",0.9200303563021659,0,0,3
251,Signal transduction through IL1R WP4496,0.4754336687281101,1.2176375404530744,0.9053474891011196,"['IRAK2', 'IL1RAP', 'MAP2K6']",0.9200303563021659,0,0,3
252,Senescence and Autophagy in Cancer WP615,0.4770527773418638,1.0824295010845988,0.8011365440261151,"['ATG3', 'GABARAPL1', 'CDKN1A', 'CEBPB', 'MAP1LC3A', 'PLAT', 'IGF1', 'ATG14']",0.9200303563021659,0,0,8
253,Endothelin Pathways WP2197,0.48979160007287903,1.298706896551724,0.9269848843337968,"['RAMP1', 'CALM2']",0.9262206911884016,0,0,2
254,Fatty Acid Biosynthesis WP357,0.48979160007287903,1.298706896551724,0.9269848843337968,"['ACSL1', 'SCD']",0.9262206911884016,0,0,2
255,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.48979160007287903,1.298706896551724,0.9269848843337968,"['PXN', 'ITGAV']",0.9262206911884016,0,0,2
256,PKC-gamma calcium signaling pathway in ataxia WP4760,0.48979160007287903,1.298706896551724,0.9269848843337968,"['CACNA1A', 'PDK1']",0.9262206911884016,0,0,2
257,Purinergic signaling WP4900,0.48979160007287903,1.298706896551724,0.9269848843337968,"['P2RY12', 'P2RY13']",0.9262206911884016,0,0,2
258,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5087102020163569,1.0569931215198165,0.7143970992950803,"['CCND3', 'PDE4D', 'APEX1', 'RPS6', 'STAT3', 'TTF2', 'MAP2K6']",0.9313138014426529,0,0,7
259,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5095609396913586,1.0821621621621622,0.729600035076526,"['KIRREL3', 'CDKN1A', 'NOTCH1', 'ITGAV', 'TLR4']",0.9313138014426529,0,0,5
260,Parkinson's disease pathway WP2371,0.5110929046328612,1.1458214353702647,0.7690798113645093,"['PINK1', 'LRRK2', 'CYCS']",0.9313138014426529,0,0,3
261,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5110929046328612,1.1458214353702647,0.7690798113645093,"['CALM3', 'CALM2', 'CREB5']",0.9313138014426529,0,0,3
262,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5116477057308402,1.6232508073196985,1.0877711517792081,['NOTCH1'],0.9313138014426529,0,0,1
263,Cell Differentiation - Index WP2029,0.5116477057308402,1.6232508073196985,1.0877711517792081,['STAT3'],0.9313138014426529,0,0,1
264,Cells and molecules involved in local acute inflammatory response  WP4493,0.5116477057308402,1.6232508073196985,1.0877711517792081,['SELPLG'],0.9313138014426529,0,0,1
265,GDNF/RET signaling axis WP4830,0.5116477057308402,1.6232508073196985,1.0877711517792081,['ROBO2'],0.9313138014426529,0,0,1
266,Hedgehog Signaling Pathway Netpath WP47,0.5116477057308402,1.6232508073196985,1.0877711517792081,['ARNTL'],0.9313138014426529,0,0,1
267,NAD+ metabolism WP3644,0.5116477057308402,1.6232508073196985,1.0877711517792081,['NAMPT'],0.9313138014426529,0,0,1
268,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5187453057651039,1.0387852494577006,0.6817986547577647,"['NOTCH1', 'WNT2B', 'WNT5A', 'GRB2', 'RBPJ', 'HIF1A', 'TGFBR1', 'MAP2K6']",0.9407097709023899,0,0,8
269,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5340547212361755,1.1804467084639498,0.7404434268335209,"['BCL6', 'H2AFZ']",0.9465920419334063,0,0,2
270,Heart Development WP1591,0.5340547212361755,1.1804467084639498,0.7404434268335209,"['NOTCH1', 'BHLHE40']",0.9465920419334063,0,0,2
271,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5340547212361755,1.1804467084639498,0.7404434268335209,"['GOT1', 'NAMPT']",0.9465920419334063,0,0,2
272,SARS coronavirus and innate immunity WP4912,0.5340547212361755,1.1804467084639498,0.7404434268335209,"['IFNAR2', 'IKBKE']",0.9465920419334063,0,0,2
273,Sphingolipid Metabolism (general overview) WP4725,0.5340547212361755,1.1804467084639498,0.7404434268335209,"['UGCG', 'PLPP3']",0.9465920419334063,0,0,2
274,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5357661748652953,1.047079337401918,0.6534376654508015,"['CDKN1A', 'TMSB4X', 'GRB2', 'PFN1', 'PFN2']",0.9465920419334063,0,0,5
275,Modulators of TCR signaling and T cell activation WP5072,0.5357661748652953,1.047079337401918,0.6534376654508015,"['NDUFB10', 'RASA2', 'ELOB', 'MAP3K8', 'GRB2']",0.9465920419334063,0,0,5
276,Melatonin metabolism and effects WP3298,0.5454264827979516,1.0819848975188782,0.6558854529200301,"['PER3', 'CALM2', 'ARNTL']",0.9465920419334063,0,0,3
277,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5540445085345216,1.0386177105831533,0.6133144092765912,"['PXN', 'STAT3', 'GAB1', 'GRB2']",0.9465920419334063,0,0,4
278,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5613120239902524,1.0141891891891892,0.5856722849373839,"['RPS6KA5', 'IRAK2', 'MAP3K8', 'IL1RAP', 'MAP2K6']",0.9465920419334063,0,0,5
279,Cell migration and invasion through p75NTR WP4561,0.5756064339920219,1.081896551724138,0.5975651407850348,"['TIAM1', 'STAT3']",0.9465920419334063,0,0,2
280,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5756064339920219,1.081896551724138,0.5975651407850348,"['ANGPT2', 'TGFBR1']",0.9465920419334063,0,0,2
281,Sphingolipid Metabolism (integrated pathway) WP4726,0.5756064339920219,1.081896551724138,0.5975651407850348,"['UGCG', 'PLPP3']",0.9465920419334063,0,0,2
282,15q13.3 copy number variation syndrome WP4942,0.5768921569963513,1.2983853606027986,0.7142416997396684,['OTUD7A'],0.9465920419334063,0,0,1
283,Aspirin and miRNAs WP4707,0.5768921569963513,1.2983853606027986,0.7142416997396684,['PDK1'],0.9465920419334063,0,0,1
284,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.5768921569963513,1.2983853606027986,0.7142416997396684,['SMAD6'],0.9465920419334063,0,0,1
285,Cytokines and Inflammatory Response WP530,0.5768921569963513,1.2983853606027986,0.7142416997396684,['IL15'],0.9465920419334063,0,0,1
286,Fatty acid transporters WP5061,0.5768921569963513,1.2983853606027986,0.7142416997396684,['ACSL1'],0.9465920419334063,0,0,1
287,FOXP3 in COVID-19 WP5063,0.5768921569963513,1.2983853606027986,0.7142416997396684,['STAT3'],0.9465920419334063,0,0,1
288,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.5768921569963513,1.2983853606027986,0.7142416997396684,['HMGCS1'],0.9465920419334063,0,0,1
289,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5768921569963513,1.2983853606027986,0.7142416997396684,['ITGAV'],0.9465920419334063,0,0,1
290,Pilocytic astrocytoma WP2253,0.5768921569963513,1.2983853606027986,0.7142416997396684,['GRB2'],0.9465920419334063,0,0,1
291,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5768921569963513,1.2983853606027986,0.7142416997396684,['IL4R'],0.9465920419334063,0,0,1
292,Vitamin A and carotenoid metabolism WP716,0.5768921569963513,1.2983853606027986,0.7142416997396684,['BCO2'],0.9465920419334063,0,0,1
293,Hematopoietic Stem Cell Differentiation WP2849,0.578308970518161,1.0248679952307955,0.5612658850972376,"['NOTCH1', 'PIM1', 'RUNX1']",0.9465920419334063,0,0,3
294,Prion disease pathway WP3995,0.578308970518161,1.0248679952307955,0.5612658850972376,"['HSPA5', 'STAT3', 'HSP90B1']",0.9465920419334063,0,0,3
295,Hepatitis B infection WP4666,0.5815889885661981,0.973202614379085,0.5274673364511705,"['CDKN1A', 'STAT3', 'CYCS', 'BAX', 'GRB2', 'IKBKE', 'JAK3', 'TLR4', 'TGFBR1', 'MAP2K6', 'CREB5', 'TLR2']",0.9465920419334063,0,0,12
296,PDGF Pathway WP2526,0.5820737592491345,0.9985047350058149,0.5403489304047565,"['TIAM1', 'STAT3', 'PDGFB', 'GRB2']",0.9465920419334063,0,0,4
297,TGF-beta Receptor Signaling WP560,0.5820737592491345,0.9985047350058149,0.5403489304047565,"['STAT3', 'SPP1', 'SMAD6', 'TGFBR1']",0.9465920419334063,0,0,4
298,Ebola Virus Pathway on Host WP4217,0.6057570795774523,0.9539641943734015,0.4781995768768581,"['BST2', 'TIAM1', 'SCIN', 'RASA2', 'ITGAV', 'IQGAP1', 'IKBKE', 'TLR4', 'ACTG1', 'RHOB']",0.9465920419334063,0,0,10
299,Cytosolic DNA-sensing pathway WP4655,0.6090594996506812,0.9613630909527238,0.4766816169349676,"['CASP1', 'IL18', 'TMEM173', 'IKBKE']",0.9465920419334063,0,0,4
300,IL-2 signaling pathway WP49,0.6090594996506812,0.9613630909527238,0.4766816169349676,"['STAT3', 'RPS6', 'GRB2', 'JAK3']",0.9465920419334063,0,0,4
301,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6090594996506812,0.9613630909527238,0.4766816169349676,"['ATG3', 'MAP1LC3A', 'ATG14', 'FTL']",0.9465920419334063,0,0,4
302,Aryl Hydrocarbon Receptor Netpath WP2586,0.6096510363662441,0.973462783171521,0.48173612284108863,"['CDKN1A', 'HPGDS', 'HSP90AA1']",0.9465920419334063,0,0,3
303,Small cell lung cancer WP4658,0.6101656348875412,0.9542130365659778,0.4714049294237669,"['CDKN1A', 'CYCS', 'BAX', 'ITGAV', 'E2F3']",0.9465920419334063,0,0,5
304,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6143811631348735,0.9985079575596817,0.4864129233876551,"['RPS6', 'SGK1']",0.9465920419334063,0,0,2
305,Overview of interferons-mediated signaling pathway WP4558,0.6143811631348735,0.9985079575596817,0.4864129233876551,"['IFNAR2', 'IL10RB']",0.9465920419334063,0,0,2
306,SARS-CoV-2 mitochondrial interactions WP5038,0.6143811631348735,0.9985079575596817,0.4864129233876551,"['TMEM173', 'IKBKE']",0.9465920419334063,0,0,2
307,TNF-alpha signaling pathway WP231,0.6170277101527282,0.9435614277262867,0.45559046883337717,"['HSP90AA1', 'BAX', 'MAP3K8', 'GRB2', 'PYGL', 'KSR2', 'TNFRSF1B', 'MAP2K6']",0.9465920419334063,0,0,8
308,Fragile X Syndrome  WP4549,0.62530459930356,0.938663306798007,0.44071780637045266,"['SH3GL3', 'GRIP1', 'GRM5', 'DUSP3', 'GAB1', 'GRB2', 'SLC6A1', 'GRIN2B', 'GABRG2', 'PDK1', 'HCN1']",0.9465920419334063,0,0,11
309,Cell Differentiation - Index expanded WP2023,0.6334279663221309,1.0818083961248655,0.49396344253494673,['STAT3'],0.9465920419334063,0,0,1
310,Estrogen Receptor Pathway WP2881,0.6334279663221309,1.0818083961248655,0.49396344253494673,['STAT3'],0.9465920419334063,0,0,1
311,FOXA2 pathway WP5066,0.6334279663221309,1.0818083961248655,0.49396344253494673,['PPARGC1B'],0.9465920419334063,0,0,1
312,Galanin receptor pathway WP4970,0.6334279663221309,1.0818083961248655,0.49396344253494673,['CDKN1A'],0.9465920419334063,0,0,1
313,Hypertrophy Model WP516,0.6334279663221309,1.0818083961248655,0.49396344253494673,['IL18'],0.9465920419334063,0,0,1
314,Nanoparticle triggered regulated necrosis WP2513,0.6334279663221309,1.0818083961248655,0.49396344253494673,['FTL'],0.9465920419334063,0,0,1
315,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6334279663221309,1.0818083961248655,0.49396344253494673,['ANAPC11'],0.9465920419334063,0,0,1
316,Type III interferon signaling WP2113,0.6334279663221309,1.0818083961248655,0.49396344253494673,['IL10RB'],0.9465920419334063,0,0,1
317,Metapathway biotransformation Phase I and II WP702,0.6349472139227975,0.9268744214748534,0.42099879275564045,"['CYP51A1', 'SULT4A1', 'HS3ST4', 'GAL3ST4']",0.9465920419334063,0,0,4
318,Glycogen Synthesis and Degradation WP500,0.6393948591327406,0.9269533055940823,0.4145641842235537,"['CALM3', 'PYGL', 'CALM2']",0.9465920419334063,0,0,3
319,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6393948591327406,0.9269533055940823,0.4145641842235537,"['SLC12A5', 'STAT3', 'GABRG2']",0.9465920419334063,0,0,3
320,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6393948591327406,0.9269533055940823,0.4145641842235537,"['CCND3', 'WNT2B', 'WNT5A']",0.9465920419334063,0,0,3
321,16p11.2 distal deletion syndrome WP4950,0.6503790927616054,0.9270320197044335,0.3988090510862642,"['INSR', 'GRB2']",0.9465920419334063,0,0,2
322,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6503790927616054,0.9270320197044335,0.3988090510862642,"['WNT5A', 'TGFBR1']",0.9465920419334063,0,0,2
323,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.6503790927616054,0.9270320197044335,0.3988090510862642,"['ATG3', 'MAP1LC3A']",0.9465920419334063,0,0,2
324,Oxidative Stress WP408,0.6503790927616054,0.9270320197044335,0.3988090510862642,"['HMOX1', 'SOD2']",0.9465920419334063,0,0,2
325,Proximal tubule transport WP4917,0.6503790927616054,0.9270320197044335,0.3988090510862642,"['SLC7A8', 'ATP6V1F']",0.9465920419334063,0,0,2
326,DNA damage response WP707,0.6596981561557451,0.8947642809264914,0.3721976817756132,"['CDKN1A', 'CCND3', 'CYCS', 'BAX']",0.9465920419334063,0,0,4
327,miRNA regulation of DNA damage response WP1530,0.6596981561557451,0.8947642809264914,0.3721976817756132,"['CDKN1A', 'CCND3', 'CYCS', 'BAX']",0.9465920419334063,0,0,4
328,Regulation of Microtubule Cytoskeleton WP2038,0.6596981561557451,0.8947642809264914,0.3721976817756132,"['TIAM1', 'STMN1', 'STAT3', 'TPPP']",0.9465920419334063,0,0,4
329,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6675097449882927,0.8846719623418653,0.35758554803464987,"['MAP1LC3A', 'IGF1', 'PDK1']",0.9465920419334063,0,0,3
330,G1 to S cell cycle control WP45,0.6675097449882927,0.8846719623418653,0.35758554803464987,"['CDKN1A', 'CCND3', 'E2F3']",0.9465920419334063,0,0,3
331,Ras signaling WP4223,0.6718635040465365,0.9043927648578811,0.3596770731888456,"['TIAM1', 'GNG10', 'GNG3', 'INSR', 'RASA2', 'GAB1', 'CALM3', 'GRB2', 'KSR2', 'GRIN2B', 'CALM2', 'RASGRP3']",0.9465920419334063,0,0,12
332,Interferon type I signaling pathways WP585,0.6771602284963251,0.8764061358655953,0.3416646181620692,"['IFNAR2', 'RPS6KA5', 'RPS6', 'STAT3', 'MAP2K6']",0.9465920419334063,0,0,5
333,BMP Signaling Pathway in Eyelid Development WP3927,0.6824164523438888,0.9271105643549131,0.3542630142118608,['NOTCH1'],0.9465920419334063,0,0,1
334,Cytosine methylation WP3585,0.6824164523438888,0.9271105643549131,0.3542630142118608,['IDH1'],0.9465920419334063,0,0,1
335,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6824164523438888,0.9271105643549131,0.3542630142118608,['PPARD'],0.9465920419334063,0,0,1
336,ERK Pathway in Huntington's Disease WP3853,0.6824164523438888,0.9271105643549131,0.3542630142118608,['RPS6KA5'],0.9465920419334063,0,0,1
337,Globo Sphingolipid Metabolism WP1424,0.6824164523438888,0.9271105643549131,0.3542630142118608,['ST6GALNAC5'],0.9465920419334063,0,0,1
338,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6824164523438888,0.9271105643549131,0.3542630142118608,['NRG3'],0.9465920419334063,0,0,1
339,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6824164523438888,0.9271105643549131,0.3542630142118608,['UGCG'],0.9465920419334063,0,0,1
340,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.6824164523438888,0.9271105643549131,0.3542630142118608,['ACSL1'],0.9465920419334063,0,0,1
341,NAD+ biosynthetic pathways WP3645,0.6824164523438888,0.9271105643549131,0.3542630142118608,['NAMPT'],0.9465920419334063,0,0,1
342,Neuroinflammation WP4919,0.6824164523438888,0.9271105643549131,0.3542630142118608,['TLR4'],0.9465920419334063,0,0,1
343,Ovarian infertility WP34,0.6824164523438888,0.9271105643549131,0.3542630142118608,['CEBPB'],0.9465920419334063,0,0,1
344,Oxidation by Cytochrome P450 WP43,0.6824164523438888,0.9271105643549131,0.3542630142118608,['CYP51A1'],0.9465920419334063,0,0,1
345,RalA downstream regulated genes WP2290,0.6824164523438888,0.9271105643549131,0.3542630142118608,['YBX3'],0.9465920419334063,0,0,1
346,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.6824164523438888,0.9271105643549131,0.3542630142118608,['TCF4'],0.9465920419334063,0,0,1
347,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6824164523438888,0.9271105643549131,0.3542630142118608,['STAT3'],0.9465920419334063,0,0,1
348,Alpha 6 Beta 4 signaling pathway WP244,0.6836498080630157,0.8650862068965517,0.3290004759670721,"['GAB1', 'GRB2']",0.9465920419334063,0,0,2
349,Intraflagellar transport proteins binding to dynein WP4532,0.6836498080630157,0.8650862068965517,0.3290004759670721,"['DYNLT3', 'DYNLL1']",0.9465920419334063,0,0,2
350,Physiological and pathological hypertrophy of the heart WP1528,0.6836498080630157,0.8650862068965517,0.3290004759670721,"['STAT3', 'CALM2']",0.9465920419334063,0,0,2
351,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6836498080630157,0.8650862068965517,0.3290004759670721,"['CALM2', 'PDK1']",0.9465920419334063,0,0,2
352,Hippo-Merlin Signaling Dysregulation WP4541,0.6926246406225488,0.8645021645021645,0.31750317753395846,"['INSR', 'ITGAX', 'CDH12', 'ITGAV', 'CDH8', 'CDH18']",0.9515651654654579,0,0,6
353,Amyotrophic lateral sclerosis (ALS) WP2447,0.693988028450999,0.8460672576333192,0.3090688503674365,"['CASP1', 'BAX', 'MAP2K6']",0.9515651654654579,0,0,3
354,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.693988028450999,0.8460672576333192,0.3090688503674365,"['IFITM3', 'BST2', 'MAP2K6']",0.9515651654654579,0,0,3
355,Endometrial cancer WP4155,0.7057041119288162,0.8367588657423535,0.2916600294989004,"['CDKN1A', 'BAX', 'CTNNA3', 'GRB2']",0.9515651654654579,0,0,4
356,GABA receptor Signaling WP4159,0.7142791262161059,0.8108836206896551,0.2728473045482787,"['SLC6A1', 'GABRG2']",0.9515651654654579,0,0,2
357,IL-7 signaling pathway WP205,0.7142791262161059,0.8108836206896551,0.2728473045482787,"['STAT3', 'JAK3']",0.9515651654654579,0,0,2
358,Nanoparticle-mediated activation of receptor signaling WP2643,0.7142791262161059,0.8108836206896551,0.2728473045482787,"['PXN', 'GRB2']",0.9515651654654579,0,0,2
359,TLR4 Signaling and Tolerance WP3851,0.7142791262161059,0.8108836206896551,0.2728473045482787,"['IKBKE', 'TLR4']",0.9515651654654579,0,0,2
360,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7188413026714714,0.8106796116504854,0.2676172285312796,"['XBP1', 'MAP1LC3A', 'HSPA5']",0.9515651654654579,0,0,3
361,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7188413026714714,0.8106796116504854,0.2676172285312796,"['IFNAR2', 'OAS1', 'IKBKE']",0.9515651654654579,0,0,3
362,Androgen receptor signaling pathway WP138,0.7231166337709378,0.840134826050319,0.27235889909437805,"['CDKN1A', 'LIMK2', 'STAT3', 'DSTN', 'STUB1', 'CALR', 'RHOB']",0.9515651654654579,0,0,7
363,1q21.1 copy number variation syndrome WP4905,0.7248642137081273,0.8110871905274488,0.26098428212614616,['GJA1'],0.9515651654654579,0,0,1
364,DNA Mismatch Repair WP531,0.7248642137081273,0.8110871905274488,0.26098428212614616,['MSH2'],0.9515651654654579,0,0,1
365,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7248642137081273,0.8110871905274488,0.26098428212614616,['BAX'],0.9515651654654579,0,0,1
366,PPAR-alpha pathway WP2878,0.7248642137081273,0.8110871905274488,0.26098428212614616,['PLTP'],0.9515651654654579,0,0,1
367,Purine metabolism and related disorders WP4224,0.7248642137081273,0.8110871905274488,0.26098428212614616,['GRM5'],0.9515651654654579,0,0,1
368,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7360183418199158,0.8102702702702703,0.2483480319889742,"['CDKN1A', 'MSH2', 'CYCS', 'BAX', 'TGFBR1']",0.9515651654654579,0,0,5
369,Wnt signaling pathway and pluripotency WP399,0.7360183418199158,0.8102702702702703,0.2483480319889742,"['CCND3', 'WNT2B', 'LRRK2', 'WNT5A', 'PPARD']",0.9515651654654579,0,0,5
370,Circadian rhythm related genes WP3594,0.7395943764705762,0.8481268459505674,0.25584033227048475,"['PHLPP1', 'PER3', 'DBP', 'KCNH7', 'NAMPT', 'BHLHE40', 'NR1D2', 'RORA', 'NR1D1', 'RPS27A', 'ARNTL']",0.9515651654654579,0,0,11
371,Notch Signaling WP268,0.7423785570099106,0.7630578093306288,0.227311854872638,"['NOTCH1', 'RBPJ']",0.9515651654654579,0,0,2
372,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7423785570099106,0.7630578093306288,0.227311854872638,"['BAX', 'TGFBR1']",0.9515651654654579,0,0,2
373,Thermogenesis WP4321,0.7452283311712079,0.810064935064935,0.23821143954573726,"['ACSL1', 'RPS6', 'GRB2', 'MGLL', 'ACTG1', 'CREB5']",0.9515651654654579,0,0,6
374,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.747023193891792,0.7857844099744747,0.22918113054562106,"['MAP3K8', 'GRB2', 'CALM2', 'PDK1']",0.9515651654654579,0,0,4
375,Head and Neck Squamous Cell Carcinoma WP4674,0.7537979713227525,0.7903757415952538,0.22338459882303188,"['CDKN1A', 'NOTCH1', 'RPS6', 'DDIT4', 'GAB1']",0.9515651654654579,0,0,5
376,Cell cycle WP179,0.7612428626881571,0.7934004770739465,0.21644190005584,"['CCND3', 'CDKN1A', 'E2F3', 'YWHAG', 'ANAPC11', 'YWHAH']",0.9515651654654579,0,0,6
377,Pancreatic adenocarcinoma pathway WP4263,0.7612428626881571,0.7934004770739465,0.21644190005584,"['TIAM1', 'CDKN1A', 'STAT3', 'BAX', 'E2F3', 'TGFBR1']",0.9515651654654579,0,0,6
378,Airway smooth muscle cell contraction WP4962,0.7616437229754386,0.7208467886616433,0.1962695597623629,['CALM2'],0.9515651654654579,0,0,1
379,Autosomal recessive Osteopetrosis pathways WP4788,0.7616437229754386,0.7208467886616433,0.1962695597623629,['TCIRG1'],0.9515651654654579,0,0,1
380,Cancer immunotherapy by PD-1 blockade WP4585,0.7616437229754386,0.7208467886616433,0.1962695597623629,['STAT3'],0.9515651654654579,0,0,1
381,Constitutive Androstane Receptor Pathway WP2875,0.7616437229754386,0.7208467886616433,0.1962695597623629,['HSP90AA1'],0.9515651654654579,0,0,1
382,Eicosanoid Synthesis WP167,0.7616437229754386,0.7208467886616433,0.1962695597623629,['LTC4S'],0.9515651654654579,0,0,1
383,Gastric Cancer Network 1 WP2361,0.7616437229754386,0.7208467886616433,0.1962695597623629,['NOTCH1'],0.9515651654654579,0,0,1
384,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7616437229754386,0.7208467886616433,0.1962695597623629,['WNT5A'],0.9515651654654579,0,0,1
385,Kallmann's Syndrome WP5074,0.7616437229754386,0.7208467886616433,0.1962695597623629,['GRB2'],0.9515651654654579,0,0,1
386,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7616437229754386,0.7208467886616433,0.1962695597623629,['MAP2K6'],0.9515651654654579,0,0,1
387,Methionine De Novo and Salvage Pathway WP3580,0.7616437229754386,0.7208467886616433,0.1962695597623629,['SRM'],0.9515651654654579,0,0,1
388,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7616437229754386,0.7208467886616433,0.1962695597623629,['HMOX1'],0.9515651654654579,0,0,1
389,Pregnane X receptor pathway WP2876,0.7616437229754386,0.7208467886616433,0.1962695597623629,['HSP90AA1'],0.9515651654654579,0,0,1
390,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7637953377212975,0.7480706995270102,0.20157169575311198,"['CCND3', 'WNT2B', 'WNT5A']",0.9518064977757708,0,0,3
391,Glycerophospholipid Biosynthetic Pathway WP2533,0.7680769272293255,0.7205459770114943,0.19012714176945994,"['PGS1', 'GK']",0.9522586393710516,0,0,2
392,Nephrotic syndrome WP4758,0.7680769272293255,0.7205459770114943,0.19012714176945994,"['YARS', 'E2F3']",0.9522586393710516,0,0,2
393,Integrin-mediated Cell Adhesion WP185,0.7765035900442847,0.7774025974025974,0.19664710675862984,"['CAPNS1', 'PXN', 'ITGAX', 'GRB2', 'ITGAV', 'MAP2K6']",0.9549310411938848,0,0,6
394,Gastrin signaling pathway WP4659,0.7828190408258673,0.7816714611275077,0.19139516488553954,"['CDKN1A', 'RPS6', 'PXN', 'STAT3', 'TCF4', 'GRB2', 'RHOB']",0.9549310411938848,0,0,7
395,DNA IR-damage and cellular response via ATR WP4016,0.7837557991964132,0.7406356062943535,0.18046163337242097,"['POLB', 'MSH2', 'BCL6', 'BRCC3']",0.9549310411938848,0,0,4
396,Insulin Signaling WP481,0.7838916403807136,0.8174750601995184,0.1990424915677208,"['SNAP25', 'PTPN1', 'XBP1', 'RPS6KA5', 'TBC1D4', 'INSR', 'GAB1', 'ENPP1', 'MAP3K8', 'GRB2', 'SGK1', 'MAP2K6']",0.9549310411938848,0,0,12
397,Common Pathways Underlying Drug Addiction WP2636,0.7839865955480659,0.7202445163610213,0.1752811228533298,"['GRM5', 'CALM2', 'ACTG1']",0.9549310411938848,0,0,3
398,Genotoxicity pathway WP4286,0.7839865955480659,0.7202445163610213,0.1752811228533298,"['CDKN1A', 'RPS27', 'CEBPD']",0.9549310411938848,0,0,3
399,Interleukin-11 Signaling Pathway WP2332,0.7839865955480659,0.7202445163610213,0.1752811228533298,"['STAT3', 'RPS6', 'GRB2']",0.9549310411938848,0,0,3
400,Canonical and non-canonical TGF-B signaling WP3874,0.7935111816333505,0.6486544671689989,0.1500257658034807,['TGFBR1'],0.9592915681189703,0,0,1
401,Imatinib and Chronic Myeloid Leukemia WP3640,0.7935111816333505,0.6486544671689989,0.1500257658034807,['PIM1'],0.9592915681189703,0,0,1
402,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.7935111816333505,0.6486544671689989,0.1500257658034807,['IDH1'],0.9592915681189703,0,0,1
403,IL-6 signaling pathway WP364,0.8027287553467773,0.6944059177068885,0.15258765308919373,"['STAT3', 'GAB1', 'GRB2']",0.9592915681189703,0,0,3
404,Autophagy WP4923,0.8128342242278043,0.6482758620689655,0.13434097288068936,"['ATG3', 'ATG14']",0.9592915681189703,0,0,2
405,miRNA regulation of prostate cancer signaling pathways WP3981,0.8128342242278043,0.6482758620689655,0.13434097288068936,"['CDKN1A', 'GRB2']",0.9592915681189703,0,0,2
406,Corticotropin-releasing hormone signaling pathway WP2355,0.8159782139820916,0.7196396396396396,0.1463514028766936,"['GJA1', 'HSP90AA1', 'IL18', 'TCF4', 'TLR4']",0.9592915681189703,0,0,5
407,Osteoblast differentiation WP4787,0.8161142123689704,0.7003677543634347,0.1423154054142686,"['NOTCH1', 'WNT2B', 'WNT5A', 'RBPJ']",0.9592915681189703,0,0,4
408,ErbB signaling pathway WP673,0.8178702723889143,0.7330311198235726,0.14737704002971802,"['CDKN1A', 'NRG3', 'NCK2', 'GAB1', 'NRG1', 'GRB2']",0.9592915681189703,0,0,6
409,G Protein Signaling Pathways WP35,0.8178702723889143,0.7330311198235726,0.14737704002971802,"['GNG10', 'GNG3', 'PDE4D', 'PDE4B', 'PDE8B', 'CALM2']",0.9592915681189703,0,0,6
410,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8184341710350983,0.7819655861005154,0.15667643254174415,"['GRIP1', 'TIAM1', 'RAB3A', 'RPS6KA5', 'RPS6', 'STAT3', 'NCK2', 'SPP1', 'GRB2', 'YBX1', 'GRIN2B']",0.9592915681189703,0,0,11
411,Energy Metabolism WP1541,0.8200854371548763,0.6703492913737306,0.13296160498406806,"['ESRRA', 'PPARGC1B', 'PPARD']",0.9592915681189703,0,0,3
412,IL-5 signaling pathway WP127,0.8200854371548763,0.6703492913737306,0.13296160498406806,"['STAT3', 'RPS6', 'GRB2']",0.9592915681189703,0,0,3
413,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8211220006944272,0.5895880223113807,0.11619811843027197,['MAP2K6'],0.9592915681189703,0,0,1
414,Ebstein-Barr virus LMP1 signaling WP262,0.8211220006944272,0.5895880223113807,0.11619811843027197,['HSP90AA1'],0.9592915681189703,0,0,1
415,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8211220006944272,0.5895880223113807,0.11619811843027197,['CDKN1A'],0.9592915681189703,0,0,1
416,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8211220006944272,0.5895880223113807,0.11619811843027197,['BAX'],0.9592915681189703,0,0,1
417,Chemokine signaling pathway WP3929,0.8286638288100332,0.7562502643935869,0.14213021933492118,"['CX3CR1', 'TIAM1', 'GNG10', 'GNG3', 'CXCL12', 'PXN', 'STAT3', 'GRB2', 'JAK3']",0.9657808652318374,0,0,9
418,AGE/RAGE pathway WP2324,0.8307409225195606,0.6818233488689326,0.12643547997545151,"['INSR', 'STAT3', 'CYCS', 'HIF1A']",0.9658853788146087,0,0,4
419,Splicing factor NOVA regulated synaptic proteins WP4148,0.8361241355911617,0.6478964401294498,0.11595933175453414,"['EPB41L3', 'GRIN2B', 'GABRG2']",0.9698241763658821,0,0,3
420,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.8450442218807092,0.5403659849300323,0.09097943201577516,['RPS6KA5'],0.9707618658115517,0,0,1
421,BDNF-TrkB Signaling WP3676,0.8497113033364366,0.5891457680250783,0.09594747284125715,"['GAB1', 'GRB2']",0.9707618658115517,0,0,2
422,MAPK Cascade WP422,0.8497113033364366,0.5891457680250783,0.09594747284125715,"['GRB2', 'MAP2K6']",0.9707618658115517,0,0,2
423,Neural Crest Cell Migration during Development WP4564,0.8497113033364366,0.5891457680250783,0.09594747284125715,"['TIAM1', 'STAT3']",0.9707618658115517,0,0,2
424,PDGFR-beta pathway WP3972,0.8497113033364366,0.5891457680250783,0.09594747284125715,"['STAT3', 'GRB2']",0.9707618658115517,0,0,2
425,Target Of Rapamycin (TOR) Signaling WP1471,0.8497113033364366,0.5891457680250783,0.09594747284125715,"['PRR5', 'DDIT4']",0.9707618658115517,0,0,2
426,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8509147218841996,0.6268921599331871,0.10120757962360794,"['CXCL12', 'TMEM173', 'IKBKE']",0.9707618658115517,0,0,3
427,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8538155988772888,0.6743243243243243,0.10657023973814635,"['HMGCS1', 'SCD', 'CYP51A1', 'SEC24D', 'PPARGC1B']",0.9709721809124421,0,0,5
428,Kit receptor signaling pathway WP304,0.8570927275955507,0.6475161987041037,0.0998529329797363,"['RPS6', 'STAT3', 'GRB2', 'SOCS6']",0.9709721809124421,0,0,4
429,Pathways affected in adenoid cystic carcinoma WP3651,0.8570927275955507,0.6475161987041037,0.0998529329797363,"['CEBPA', 'NOTCH1', 'NFIB', 'MAGI2']",0.9709721809124421,0,0,4
430,Ethanol effects on histone modifications WP3996,0.8657701534643785,0.4987165686842759,0.07188292025407977,['HDAC4'],0.9735412308757929,0,0,1
431,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8657701534643785,0.4987165686842759,0.07188292025407977,['RAB27A'],0.9735412308757929,0,0,1
432,MTHFR deficiency WP4288,0.8657701534643785,0.4987165686842759,0.07188292025407977,['CYCS'],0.9735412308757929,0,0,1
433,Male infertility WP4673,0.8689048374080852,0.6316177632618659,0.08875598155253413,"['POLB', 'INSR', 'SOD2', 'ARNTL']",0.9735412308757929,0,0,4
434,Leptin signaling pathway WP2034,0.8752611926484446,0.6471351351351351,0.08621971099131179,"['PTPN1', 'RPS6', 'STAT3', 'BAX', 'GRB2']",0.9735412308757929,0,0,5
435,AMP-activated protein kinase (AMPK) signaling WP1403,0.877035598091623,0.588702559576346,0.07724230687123262,"['CDKN1A', 'INSR', 'PPARGC1B']",0.9735412308757929,0,0,3
436,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.877035598091623,0.588702559576346,0.07724230687123262,"['IFI27L2', 'TLR4', 'TLR2']",0.9735412308757929,0,0,3
437,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8798520802327348,0.5398706896551724,0.06910424527795626,"['CYCS', 'ACTG1']",0.9735412308757929,0,0,2
438,B Cell Receptor Signaling Pathway WP23,0.8812292028380408,0.6756520754839023,0.08542777601675064,"['BCL6', 'GAB1', 'GRB2', 'E2F3', 'PIK3AP1', 'RASGRP3', 'MAP2K6']",0.9735412308757929,0,0,7
439,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8837264580676653,0.46301706904505613,0.05723247533808695,['BAX'],0.9735412308757929,0,0,1
440,22q11.2 copy number variation syndrome WP4657,0.8885072508467574,0.571292594707786,0.06753390908319377,"['OAT', 'EMC10', 'ARNTL']",0.9735412308757929,0,0,3
441,Rett syndrome causing genes WP4312,0.8885072508467574,0.571292594707786,0.06753390908319377,"['CECR2', 'TCF4', 'GRIN2B']",0.9735412308757929,0,0,3
442,Wnt signaling WP428,0.8900254317264623,0.6020392787181676,0.07014073167432783,"['CCND3', 'WNT2B', 'WNT5A', 'PRICKLE2']",0.9735412308757929,0,0,4
443,Neural Crest Cell Migration in Cancer WP4565,0.8927329052899308,0.5181896551724138,0.05879786143410929,"['TIAM1', 'STAT3']",0.9735412308757929,0,0,2
444,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8927329052899308,0.5181896551724138,0.05879786143410929,"['STAT3', 'RPS6']",0.9735412308757929,0,0,2
445,EGF/EGFR signaling pathway WP437,0.8932712341753748,0.7175018155410312,0.0809808499766235,"['SH3GL3', 'NDUFA13', 'GJA1', 'PLSCR1', 'RPS6KA5', 'LIMK2', 'STMN1', 'STAT3', 'NCK2', 'GAB1', 'GRB2', 'IQGAP1']",0.9735412308757929,0,0,12
446,miRNAs involvement in the immune response in sepsis WP4329,0.899282897655231,0.43207750269106565,0.045868316592828653,['TLR4'],0.9735412308757929,0,0,1
447,Sphingolipid pathway WP1422,0.899282897655231,0.43207750269106565,0.045868316592828653,['UGCG'],0.9735412308757929,0,0,1
448,Vitamin D in inflammatory diseases WP4482,0.899282897655231,0.43207750269106565,0.045868316592828653,['MAP2K6'],0.9735412308757929,0,0,1
449,Pathways Regulating Hippo Signaling WP4540,0.899423894368788,0.5882583938739446,0.062355882704368086,"['INSR', 'CDH12', 'CDH8', 'CDH18']",0.9735412308757929,0,0,4
450,Integrated breast cancer pathway WP1984,0.9098907721233338,0.6542738680359154,0.06178355067529206,"['USP15', 'MSH2', 'BAX', 'FAU', 'SMAD6', 'BACH1', 'TGFBR1', 'RASGRP3']",0.9826820338932005,0,0,8
451,Copper homeostasis WP3286,0.9147294613226656,0.4796455938697318,0.04274933836378795,"['STEAP3', 'ATOX1']",0.9850297541687301,0,0,2
452,Glioblastoma signaling pathways WP2261,0.9161182075807942,0.5624941309043102,0.049280040528621526,"['CDKN1A', 'GAB1', 'GRB2', 'MAP2K6']",0.9850297541687301,0,0,4
453,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9240682010643914,0.4624384236453202,0.03651848456947198,"['IFNAR2', 'CXCL12']",0.9874187026280918,0,0,2
454,Mesodermal commitment pathway WP2857,0.9242291299125737,0.5772200772200772,0.04548220720789506,"['BHLHE40', 'RGS10', 'RPL38', 'TCF4', 'SMAD6']",0.9874187026280918,0,0,5
455,Eukaryotic Transcription Initiation WP405,0.9244352051353535,0.38111821693155196,0.029945341354449696,['POLR2I'],0.9874187026280918,0,0,1
456,Focal Adhesion WP306,0.9324335809798417,0.6223244387528422,0.0435361728272228,"['CCND3', 'PXN', 'PDGFB', 'SPP1', 'GRB2', 'ITGAV', 'IGF1', 'ACTG1']",0.9895229088643674,0,0,8
457,IL-1 signaling pathway WP195,0.9326606806614389,0.4976350510331093,0.03469204565175209,"['IRAK2', 'IL1RAP', 'MAP2K6']",0.9895229088643674,0,0,3
458,One-carbon metabolism and related pathways WP3940,0.9345494139274582,0.3598851811984212,0.024360907217719194,['SOD2'],0.9895229088643674,0,0,1
459,Type II interferon signaling (IFNG) WP619,0.9345494139274582,0.3598851811984212,0.024360907217719194,['OAS1'],0.9895229088643674,0,0,1
460,ATM Signaling Pathway WP2516,0.9433110751664657,0.34088720185825166,0.019893895023525145,['CDKN1A'],0.9936478033921927,0,0,1
461,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9433110751664657,0.34088720185825166,0.019893895023525145,['VMP1'],0.9936478033921927,0,0,1
462,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.946623318869517,0.4174777530589544,0.02290033613438983,"['CACNA1C', 'GRIN2B']",0.9936478033921927,0,0,2
463,Wnt Signaling Pathway WP363,0.946623318869517,0.4174777530589544,0.02290033613438983,"['GJA1', 'TCF4']",0.9936478033921927,0,0,2
464,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9509008923225761,0.323789020452099,0.01630129941938745,['PDK1'],0.993844803588757,0,0,1
465,Prader-Willi and Angelman Syndrome WP3998,0.9509008923225761,0.323789020452099,0.01630129941938745,['GABRG2'],0.993844803588757,0,0,1
466,Proteasome Degradation WP183,0.9556967906162153,0.4510423722435463,0.020438796050780677,"['PSMD5', 'H2AFZ', 'PSMB10']",0.9956649164015977,0,0,3
467,T-cell receptor (TCR) signaling pathway WP69,0.9567397447727286,0.4876319328415991,0.021564972936850262,"['CD83', 'MAP3K8', 'GRB2', 'OPRM1']",0.9956649164015977,0,0,4
468,16p11.2 proximal deletion syndrome WP4949,0.9642243595475917,0.43085221143473573,0.015696494680043707,"['ASPHD1', 'MVP', 'MAP2K6']",0.997801409628785,0,0,3
469,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9681033860483751,0.28141526653250337,0.009122468056137024,['PDK1'],0.997801409628785,0,0,1
470,Translation Factors WP107,0.9707157943713637,0.35919540229885055,0.010675843132649214,"['EIF4A2', 'EEF1B2']",0.997801409628785,0,0,2
471,IL-3 signaling pathway WP286,0.9740724740995361,0.3494291705498602,0.009179353839634401,"['STAT3', 'GRB2']",0.997801409628785,0,0,2
472,TGF-beta Signaling Pathway WP366,0.9756842306703974,0.49600399600399603,0.012209772783828586,"['CDKN1A', 'LIMK2', 'GRB2', 'TGFBR1', 'PDK1', 'MAP2K6']",0.997801409628785,0,0,6
473,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9760771194472248,0.25881593110871903,0.006266886099454702,['HDAC4'],0.997801409628785,0,0,1
474,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9777728617219673,0.4896432681242808,0.011006144410437959,"['PTPN1', 'RPS6KA5', 'SCD', 'INSR', 'MAP3K8', 'MAP2K6']",0.997801409628785,0,0,6
475,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9792826249195478,0.2488200712097375,0.005209045891633967,['ACTG1'],0.997801409628785,0,0,1
476,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9820589692218479,0.2395646453773472,0.00433705972730203,['GRB2'],0.997801409628785,0,0,1
477,ATM Signaling Network in Development and Disease  WP3878,0.9844635554307505,0.23097032139012763,0.0036166256670324168,['HDAC4'],0.997801409628785,0,0,1
478,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9844635554307505,0.23097032139012763,0.0036166256670324168,['BAX'],0.997801409628785,0,0,1
479,DNA Repair Pathways Full Network WP4946,0.9867468864574837,0.3585041352031643,0.004783061717256184,"['POLB', 'MSH2', 'APEX1']",0.997801409628785,0,0,3
480,Ciliary landscape WP4352,0.9921864965664297,0.5016983695652174,0.003935416729594903,"['CTSA', 'DOCK5', 'MSH2', 'TBC1D4', 'DYNLT3', 'IQGAP1', 'IQGAP2', 'DYNLL1', 'COX6C', 'CALM2']",0.997801409628785,0,0,10
481,RANKL/RANK signaling pathway WP2018,0.9924359329196545,0.195811723260593,0.0014867631135383468,['MAP2K6'],0.997801409628785,0,0,1
482,Ciliopathies WP4803,0.9933232330851396,0.32233009708737864,0.0021593396804645494,"['KIAA0586', 'MAK', 'CCDC65']",0.997801409628785,0,0,3
483,Joubert Syndrome WP4656,0.9943288827127125,0.18456097185914194,0.0010496460722565649,['KIAA0586'],0.997801409628785,0,0,1
484,Endoderm differentiation WP2853,0.994705987501451,0.3118279569892473,0.0016552063192489849,"['NOTCH1', 'RGS10', 'TCF4']",0.997801409628785,0,0,3
485,Genes related to primary cilium development (based on CRISPR) WP4536,0.9957483203085612,0.17452651790649637,0.0007436127760344688,['DYNLL1'],0.997801409628785,0,0,1
486,mRNA Processing WP411,0.9994218533350823,0.27603985229568734,0.0001596376714307095,"['LSM7', 'SNRPD1', 'SNRPG', 'YBX1']",0.9994218533350823,0,0,4
